Question 1

What is Cisplatin?

Accepted Answer

Cisplatin is a platinum-based chemotherapy medication that belongs to a class of drugs known as alkylating agents. It works by binding to DNA and interfering with the repair mechanism of cells, which prevents cancer cells from multiplying and leads to their eventual destruction.

This medication is a foundational treatment used in cancer treatment plans to target and eliminate rapidly dividing cells within the body.

Question 2

What is Cisplatin used for?

Accepted Answer

Cisplatin is used to treat:

Testicular cancer

Ovarian cancer

Bladder cancer

Question 3

How does Cisplatin work?

Accepted Answer

Mechanism of Action

Cisplatin belongs to a group of medicines known as platinum-containing compounds. It is used to treat various types of cancer by slowing or stopping the growth of malignant cells.

The medication works through the following process:

DNA Binding: Once cisplatin enters the body, it targets the DNA inside cells. It attaches itself to the DNA strands, creating cross-links.

Preventing Replication: These cross-links act as a physical barrier that prevents the cell from copying its genetic material. Without the ability to replicate DNA, the cell cannot divide to create new cancer cells.

Cell Death: When a cell's DNA is damaged and cannot be repaired or replicated, the cell eventually dies.

Because cancer cells generally divide more rapidly than healthy cells, they are more susceptible to the effects of cisplatin. However, the drug can also affect some healthy cells that divide quickly, which contributes to its side effects.

Question 4

What are the brand names for Cisplatin?

Accepted Answer

Cisplatin is sold under the brand names:

Platinol

Cisplatin Ebewe

Cisplatin Hospira

Question 5

What are the active ingredients in Cisplatin?

Accepted Answer

The active ingredient in Cisplatin is cisplatin .

Question 6

What are the side effects of Cisplatin?

Accepted Answer

Common side effects of Cisplatin may include:

nausea

vomiting

loss of appetite

and others.

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Cisplatin?

Accepted Answer

Cisplatin belongs to the alkylating agent drug class.

Question 8

What is the dosage of Cisplatin and how do I take it?

Accepted Answer

Administration

Cisplatin is given as an injection into a vein (intravenous infusion) by a doctor or nurse in a hospital or clinic. The infusion is typically delivered slowly over a period of several hours.

Treatment Schedule

This medication is usually given in cycles. A cycle typically involves receiving the medication on one or more days, followed by a rest period of several weeks to allow the body to recover. The specific schedule depends on the condition being treated and how the body responds to the medication.

Hydration Requirements

To help prevent kidney damage, it is important to receive plenty of fluids before, during, and after each dose of cisplatin. Healthcare providers will often provide intravenous fluids and may instruct patients to drink extra water or other liquids.

Missed Doses

Because cisplatin is administered by a healthcare professional on a specific schedule, it is important to keep all appointments. If an appointment is missed, contact the healthcare provider immediately to reschedule the treatment.

Question 9

Is Cisplatin safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Cisplatin can cause harm to a developing fetus. Research suggests that exposure to this medication during pregnancy may result in birth defects or other serious complications. Because of these risks, healthcare providers generally advise the following:

Pregnancy Prevention: Patients who can become pregnant are typically advised to use effective birth control during treatment.

Notification: If pregnancy is suspected or occurs during treatment, it is important to inform a healthcare professional immediately to evaluate the risks.

Fertility Considerations: Cisplatin may also affect fertility in both men and women. Men are often advised to use contraception to avoid fathering a child while receiving this medication.

Breastfeeding

There is limited information regarding whether cisplatin is present in human breast milk. Due to the potential for severe side effects in a nursing infant, breastfeeding is generally not recommended while undergoing treatment with cisplatin. Patients are encouraged to discuss alternative feeding methods with their healthcare team.

Question 10

What forms and strengths does Cisplatin come in?

Accepted Answer

Available Forms

Cisplatin is supplied in forms intended for administration by a healthcare professional in a medical setting. It is not available for self-administration.

Intravenous Injection: This medication is commonly provided as a sterile aqueous solution in vials.

Powder for Injection: It may also be available as a lyophilized powder that must be reconstituted into a liquid solution before use.

Cisplatin is administered as an infusion into a vein. It is not available in oral forms such as tablets or capsules.

Question 11

What is the FDA approval status of Cisplatin?

Accepted Answer

FDA Approval and Indications

Cisplatin was initially approved by the FDA in 1978. It is currently indicated for the treatment of the following conditions:

Metastatic testicular tumors, often in combination with other approved chemotherapeutic agents.

Metastatic ovarian tumors, typically as combination therapy with other agents in patients who have already received surgery or radiotherapy.

Advanced bladder cancer that is no longer responsive to local treatments like surgery or radiotherapy.

In March 2024, the FDA also approved cisplatin for use in combination with nivolumab and gemcitabine as a first-line treatment for adults with unresectable or metastatic urothelial carcinoma.

Boxed Warnings

The FDA requires a boxed warning for cisplatin due to the potential for severe adverse reactions. These include:

Nephrotoxicity: Dose-related and cumulative kidney damage is a major concern. Renal function must be monitored closely, and hydration is required before and after administration.

Ototoxicity: Hearing loss and tinnitus may occur, particularly with high doses or frequent cycles. This effect may be more severe in pediatric patients.

Nausea and Vomiting: Severe gastrointestinal distress is common and may require the use of antiemetic medications.

Myelosuppression: The drug can suppress bone marrow activity, leading to low levels of white blood cells, red blood cells, and platelets.

Peripheral Neuropathy: Nerve damage causing tingling or numbness in the extremities may occur, sometimes after prolonged treatment.

Regulatory Requirements

Because of its toxicity profile, cisplatin must be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Regular laboratory testing, including kidney function tests and hearing evaluations, is mandated during the course of therapy.

Question 12

What should I know about Cisplatin and fda?

Accepted Answer

FDA-Approved Indications

Cisplatin is indicated for the treatment of several specific types of metastatic or advanced cancers:

Metastatic Testicular Tumors: It is used in combination with other approved chemotherapeutic agents for patients who have already received appropriate surgical or radiotherapeutic procedures.

Metastatic Ovarian Tumors: It is used as a primary treatment for advanced disease in combination with other agents, or as a secondary therapy for patients who have not responded to standard treatments.

Advanced Bladder Cancer: It is used as a single agent for patients with transitional cell bladder cancer that is no longer manageable by local treatments such as surgery or radiation.

Recent FDA Approvals

In March 2024, the FDA approved the use of nivolumab in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma, a type of bladder cancer.

FDA Boxed Warnings

The FDA has issued boxed warnings for cisplatin due to the risk of severe and potentially cumulative toxicities:

Nephrotoxicity: Dose-related kidney damage is a major risk. Patients must be adequately hydrated before and after administration to reduce this risk.

Ototoxicity: Significant hearing loss or tinnitus may occur, and this effect may be more pronounced in children.

Myelosuppression: The drug can cause severe suppression of bone marrow function, leading to low levels of white blood cells, red blood cells, and platelets.

Nausea and Vomiting: Severe gastrointestinal distress is common and typically requires the use of antiemetic medications.

The FDA also highlights the risk of medication errors, specifically the potential for cisplatin to be confused with carboplatin, which has a different dosing schedule and toxicity profile.

Cisplatin

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Fda Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?